Bone disease in β-thalassaemia major

British Journal of Haematology

Volumn 103, Issue 4, 1998, Pages 897-901

  Wonke, B ^a  

^a WHITTINGTON HOSPITAL   (United Kingdom)

Author keywords

Desferrioxamine; Osteoporosis; Serum transferrin receptors; Sp1 polymorphism; Thalassaemia

Indexed keywords

DEFEROXAMINE;

BETA THALASSEMIA; BLOOD TRANSFUSION; BONE DISEASE; DNA SYNTHESIS INHIBITION; DUAL ENERGY X RAY ABSORPTIOMETRY; HISTOCOMPATIBILITY; HUMAN; IRON CHELATION; PRIORITY JOURNAL; REVIEW;

EID: 0032411621     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.01107.x     Document Type: Review

References (29)

1. 1 Anapliotou, M.L.G., Kastanias, I.T., Psara, P., Evangelou, E.A., Liparaki, M., Dimitrou, P. (1995) The contribution of hypogonadism to the development of osteoporosis in thalassaemia major; new therapeutic approaches. Clinical Endocrinology, 42, 279 287.
2. 2 Bonjour, J.P., Theniutz, G., Buchs, B., Slosman, D., Rizzoli, R. (1991) Critical years and stage of puberty for spinal and femoral bone mass accumulation during adolescence. Journal of Clinical Endocrinology and Metabolism, 73, 555 563.
3. 3 Cannel, H. (1988) The development of oral and facial signs in β thalassaemia major. British Dental Journal, 164, 50 51.
4. 4 Cazzola, M., DeStefano, P., Porchio, L., Locatelli, F., Beguin, Y., Dessi, C., Barella, S., Cao, A., Galanello, R. (1995) Relationship between transfusion regimen and suppression of erythropoiesis in β‐thalassaemia major. British Journal of Haematology, 89, 473 478.
5. 5 Compston, J.E., Cooper, C., Kanis, J.A. (1995) Bone densitometry in clinical practice. British Medical Journal, 310, 1507 1510.
6. 6 Cooley, T.B. & Lee, P. (1925) A series of cases of splenomegaly in children with anemia and peculiar bone change. Transactions of the American Pediatric Society, 37, 29.
7. 7 Currarino, G. & Erlandson, M.E. (1964) Premature fusion of epiphyses in Cooley's anaemia. Radiology, 83, 656 664.
8. 8 Dandona, P., Monor, R.K., Houlder, S., Thomas, M., Hoffbrand, A.V., Flynn, D.M. (1987) Serum 1,25‐dihydroxy vitamin D and osteocalcin concentrations in thalassaemia major. Archives of Disease in Childhood, 62, 474 477.
9. 9 De Sanctis, V., Pinamonti, A., Di Palma, A., Sprocati, M., Atti, G., Gamberini, M.R., Vullo, C. (1996) Growth and development in thalassaemia major patients with severe bone lesions due to desferrioxamine. European Journal of Pediatrics, 155, 368 372.
10. 10 Giardina, P.J., Schneider, R., Lesser, M., Simmons, B., Rodriguez, A., Gertner, J., New, M., Hilgartner, M.W. (1995) Abnormal bone metabolism in thalassaemia. Endocrine Disorders in Thalassaemia (ed. by S. Ando et al), pp. 39 46. Springer, Berlin.
11. 11 Grant, S.F.A., Reid, D.M., Blake, G., Herd, R., Fogelman, I., Ralston, S.H. (1996) Reduced bone density an osteoporosis associated with polymorphic Sp1 binding site in the collagen type α 1 gene. Nature Genetics, 1, 203 205.
12. 12 Han, K.O., Moon, I.G., Kang, Y.S., Chung, H.Y., Min, H.K., Han, I.K. (1997) Non‐association of oestrogen receptor genotypes with bone mineral density and oestrogen responsiveness to hormone replacement therapy in Korean post‐menopausal women. Journal of Clinical Endocrinology and Metabolism, 82, 991 995.
13. 13 Hanslip, J.I., Prescott, E., Agnew, J.E., Wonke, B. (1998 a) Response to bisphosphonate therapy for osteoporosis in thalassaemia major. British Journal of Haematology, 101, (Suppl. 1), 53 (abstract 124).
14. 14 Hanslip, J.I., Prescott, E., Lalloz, M., Layton, M., Wonke, B. (1998 b) The role of the Sp1 polymorphism in the development of osteoporosis in patients with thalassaemia major. British Journal of Haematology, 101, (Suppl. 1), 26 (abstract 21).
15. 15 Jensen, C.E., Tuck, S.M., Agnew, J.E., Koneru, S., Morris, R.W., Yardumian, A., Prescott, E., Hoffbrand, A.V., Wonke, B. (1998) High prevalence of low bone mass in thalassaemia major. British Journal of Haematology, 103, 911 915.
16. 16 Kasper, C.H., Wergedal, J.E., Farley, J.R., Linkhart, T.A., Turner, RT., Baylink, D.J. (1989) Androgens directly stimulate proliferation of bone cells in vitro. Endocrinology, 124, 1576 1578.
17. 17 Kaufmann, T., Coleman, M., Giardina, P., Nisce, L.X. (1991) The role of radiation therapy in the management of haematopoietic neurologic complications in thalassaemia. Acta Haematologica, 85, 156 159.
18. 18 Lawson, J.P., Albow, R.C., Pearson, A. (1981) The ribs in thalassemia. Pediatric Radiology, 140, 663 672.
19. 19 Logothetis, J., Minneapolis, M.D., Economidou, J. (1971) Cephalofacial deformities in thalassemia major (Cooley's anemia). American Journal of Diseases of Children, 121, 300 306.
20. 20 Michelson, J. & Cohen, A. (1988) Incidence and treatment of fractures in thalassaemia. Journal of Orthodontic Trauma, 2, 29 32.
21. 21 Orzincolo, C., Castaldi, G., Bariani, L., Franceschini, F., Corcione, S., Scutellari, P.N. (1988) Circumscribed lytic lesions of the thalassaemic skull. Skeletal Radiology, 17, 345 347.
22. 22 Piomelli, S., Danoff, S.J., Becker, M.H., Lipera, M.J., Travis, S.F. (1969) Prevention of bone malformations and cardiomegaly in Cooley's anemia by early hypertransfusion regimen. Annals of the New York Academy of Sciences, 165, 427 436.
23. 23 Rioja, L., Girot, R., Garabedian, M., Cournot‐Witmer, G. (1990) Bone disease in children with homozygous β‐thalassemia. Bone and Mineral, 8, 69 86.
24. 24 Seligman, P.A., Schleicher, R.B., Allen, R.H. (1979) Isolation and characterisation of the transferrin receptor from human placenta. Journal of Biological Chemistry, 254, 9943 9946.
25. 25 Shinar, E. & Rachmilewitz, E.A. (1990) Oxidative denaturation of red cells in thalassaemia. Seminars in Haematology, 27, 70 82.
26. Swedish Council on Technology Assessment in Health Care ( 1997) Methods for bone density measurement. Journal of Internal Medicine, 241, (Suppl. 739), 12 22.
27. 27 Uitterlinden, A.G., Burger, H., Huang, Q., Yue, F., McGuigan, F.E.A., Grant, S.F.A., Hofman, A., Van Leeuwen, J.P.T.M., Pols, H.A.P., Ralston, S.H. (1998) Relation of alleles of the collagen type I α 1 gene to bone density and the risk of osteoporotic fractures in post‐ menopausal women. New England Journal of Medicine, 338, 1016 1021.
28. World Health Organization ( 1985) Recommendations for transfusion treatment of beta thalassaemia major. Therapy of Thalassaemia, pp. 237 255. W.H.O., Milan.
29. World Health Organization ( 1994) Assessment of fracture risks and its application to screening for post‐menopausal osteoporosis. Technical Report Series 843. W.H.O., Geneva.